Necrotizing fasciitis in the head and neck region: an analysis of standard treatment effectiveness. | Canada Hyperbarics Skip to main content
Clinical Guideline European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - 2007

Necrotizing fasciitis in the head and neck region: an analysis of standard treatment effectiveness.

Krenk L, Nielsen HU, Christensen ME — European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - , 2007

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers conducted a retrospective study involving 19 patients treated for necrotizing fasciitis in the head and neck region between 1996 and 2004 to evaluate the effectiveness of a new standard treatment procedure introduced in 1999.

What They Found

The new treatment, which included more drastic surgical debridement, a set antibiotic regime, intravenous gamma globulin, and adjunctive hyperbaric oxygen treatment (HBO), significantly reduced mortality from 75% (6 out of 8 patients) in the pre-HBO group to 0% (0 out of 11 patients) in the HBO group.

Patients in the HBO group underwent significantly more debridement procedures (mean 3.36) and experienced a prolonged hospital stay (mean 30.8 days).

What This Means for Canadian Patients

Canadian patients with necrotizing fasciitis in the head and neck region may benefit from a comprehensive treatment approach that includes aggressive surgical debridement, specific antibiotics, intravenous gamma globulin, and hyperbaric oxygen therapy.

This multi-modal strategy could potentially improve survival rates, although it may lead to longer hospital stays.

Canadian Relevance

This study was conducted in Denmark and does not have a direct Canadian connection.

Study Limitations

The study's retrospective design and the inability to isolate a specific factor responsible for the observed change in mortality are key limitations.

Was this summary helpful?

Study Details

Study Type Clinical Guideline
Category Infection
Source Pubmed
PubMed ID 17340128
Year Published 2007
Journal European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology -
MeSH Terms Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Debridement; Denmark; Drug Therapy, Combination; Fasciitis, Necrotizing; Female; Follow-Up Studies; Head; Humans; Hyperbaric Oxygenation; Immunologic Factors; Male

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.